Cigna Corp (CI)

Currency in USD
281.36
+2.85(+1.02%)
Real-time Data·
CI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
275.32282.42
52 wk Range
239.51312.18
Key Statistics
Prev. Close
278.51
Open
279.4
Day's Range
275.32-282.42
52 wk Range
239.51-312.18
Volume
630.13K
Average Vol. (3m)
1.66M
1-Year Change
-8.2214%
Book Value / Share
161.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
342.29
Upside
+21.66%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 5 consecutive years

Cigna Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

18 Buy
6 Hold
0 Sell
Ratings:
24 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 342.29
(+21.66% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Piper Sandler
Buy370.00+31.59%346.00MaintainOct 02, 2026
Bernstein SocGen Group
Buy387.00+37.64%381.00MaintainOct 02, 2026
UBS
Buy400.00+42.26%400.00MaintainOct 01, 2026
Evercore ISI
Hold290.00+3.14%-New CoverageSep 09, 2026
Jefferies
Hold307.00+9.19%336.00DowngradeAug 04, 2026

Cigna Corp SWOT Analysis


Valuation Appeal
Trading at P/E of 12.11 with PEG ratio of 0.38, the stock offers compelling valuation alongside 45-year dividend track record and 10% free cash flow yield
Analyst Outlook
Price targets range from $303 to $325, reflecting confidence in diversified healthcare model despite near-term headwinds and transition challenges
Specialty Growth
Explore how Specialty Pharmacy emerges as strategic priority with constructive rate discussions and premium margins in complex medication distribution
PBM Transformation
Cigna navigates substantial PBM earnings decline of $700-800M through 2026, with stabilization expected in 2027 as business model restructuring concludes
Read full SWOT analysis

Cigna Corp Earnings Call Summary for Q2/2026

  • Cigna Q2 adjusted EPS of $7.78 beat estimates by 2.5%; revenue of $71.7B topped forecasts by 2.17%, yet shares fell 4.1% on investor caution.
  • Full-year 2026 adjusted EPS guidance raised to at least $30.45; Evernorth and Cigna Healthcare pre-tax earnings targets reaffirmed at $6.9B and $4.55B.
  • Specialty and Care Services pre-tax earnings surged 22% to $1.1B on faster adoption of specialty generics and biosimilars exceeding 80% penetration.
  • Pharmacy Benefit Services earnings declined year-over-year; GLP-1 growth moderating and Q2 specialty drug benefits not expected to repeat at same levels.
  • Signature rebate-free pharmacy model set for broader 2028 launch with 4% margin target; company exiting ACA exchange business to redeploy resources.
Last Updated: 07/30/2026, 09:56 AM
Read Full Transcript

Earnings

Latest Release
Jul 30, 2026
EPS / Forecast
7.78 / 7.59
Revenue / Forecast
71.7B / 70.18B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 24.18%
Dividend Yield
2.24%
Industry Median 1.99%
Annualized Payout
6.24
Paid quarterly
5-Years Growth
+25.15%
Growth Streak

CI Income Statement

Compare CI to Peers and Sector

Metrics to compare
CI
Peers
Sector
Relationship
P/E Ratio
11.5x14.1x−0.3x
PEG Ratio
0.350.580.00
Price / Book
1.7x2.2x2.6x
Price / LTM Sales
0.3x1.4x3.0x
Upside (Analyst Target)
23.6%1.5%57.9%
Fair Value Upside
Unlock13.5%7.6%Unlock

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
126.49M47.87%35.23B
Other Institutional Investors
119.10M45.07%33.17B
Public Companies & Retail Investors
18.65M7.06%5.19B
Total
264.24M100.00%73.59B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.8.87%23,438,2506,527,787
Vanguard Capital Management, LLC7.10%18,761,2555,225,197

People Also Watch

73.27
ZTS
+2.40%
82.63
DECK
+2.80%
156.63
VST
-6.05%
995.74
GEV
-0.14%
230.19
NVDA
-3.07%

FAQ

What Is the Cigna (CI) Stock Price Today?

The Cigna stock price today is 281.36 USD.

What Stock Exchange Does Cigna Trade On?

Cigna is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Cigna?

The stock symbol for Cigna is "CI."

Does Cigna Pay Dividends? What’s The Current Dividend Yield?

The Cigna dividend yield is 2.24%.

What Is the Cigna Market Cap?

As of today, Cigna market cap is 74.21B USD.

What Is Cigna's Earnings Per Share (TTM)?

The Cigna EPS (TTM) is 24.18.

When Is the Next Cigna Earnings Date?

Cigna will release its next earnings report on Oct 29, 2026.

From a Technical Analysis Perspective, Is CI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Cigna Stock Split?

Cigna has split 2 times.

How Many Employees Does Cigna Have?

Cigna has 66685 employees.

What is the current trading status of Cigna (CI)?

As of Oct 08, 2026, Cigna (CI) is trading at a price of 281.36 USD, with a previous close of 278.51 USD. The stock has fluctuated within a day range of 275.32 USD to 282.42 USD, while its 52-week range spans from 239.51 USD to 312.18 USD.

What Is Cigna (CI) Price Target According to Analysts?

The average 12-month price target for Cigna is 342.29 USD, with a high estimate of 400 USD and a low estimate of 288 USD. 18 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +21.66% Upside potential.

What Is the CI Premarket Price?

CI's last pre-market stock price is 279.00 USD. The pre-market share volume is 43,780.00, and the stock has decreased by 0.49, or 0.18%.

What Is the CI After Hours Price?

CI's last after hours stock price is 280.00 USD, the stock has decreased by 1.49, or 0.54%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.